Institute of Oncology Ljubljana (IOL) is a public health institution providing health services on the secondary and tertiary levels as well as performing educational and research activities in oncology in Slovenia. It was founded in 1938 and at that time was one of the first comprehensive cancer centres in Europe. As a principal national institution, the Institute supervises programs on the comprehensive management of cancer diseases in terms of prevention, early detection, diagnostics, treatment and rehabilitation, research and education. A multidisciplinary approach to cancer treatment and team work, significant achievements in medical work and scientific research, fruitful cooperation with local health institutions and effective integration in the network of Slovenian health care services as well as cooperation with similar institutions in Europe and the rest of the world have remained the fundamental mainstay of further progress. The Institute implements and monitors the National Cancer Control Program. The major goals of this program are to reduce cancer incidence and the cancer death rate, to ensure equality of access to treatment potential and a high quality of life to cancer survivors, and also to provide palliative care.
From 1986 there is a Department for long-term follow-up of childhood cancer survivors, where all Slovenian childhood cancer survivors have life-long follow-up for their long-term sequelae of cancer treatment. From 2008, all survivors, treated for lymphoma and sarcoma till the age of 30 years are at regular follow-up as well.
In the e-QuoL research project, IOL is involved in WP2, WP3, WP6 and WP7.